Clinical Epilepsy Trials
The MCG Department of Neurology at Georgia Regents University and the MCG Epilepsy Program
at GRU are engaged in a number of ongoing clinical research trials. The purpose of
these trials is to improve and expand treatment options for a variety of clinical
conditions, by using real-life conditions as disease models.
Ongoing Studies:
An Open-Label, Multicenter, Follow-up Trial to Evaluate the Long-Term Safety and Efficacy
of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of
150 mg/day in Subjects Aged 16 Years or Older Suffering from Epilepsy
Principal Investigator: Anthony Murro, MD
RNS System Long-Term Treatment Clinical Investigation
Principal Investigator: Anthony Murro, MD
New Studies:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study
with an Open-Label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive
Perampanel in Primary Generalized Tonic-Clonic Seizures
Principal Investigator: Yong Park, MD
An Open-label Pilot Study With an Extension Phase to Evaluate the Pharmacokinetics,
and to Generate Preliminary Safety, Tolerability, and Efficacy of Perampanel (E2007)
Oral Suspension When Given as an Adjunctive Therapy in Pediatric Subjects from 2 to
Less Than 12 Years of Age With Epilepsy
Principal Investigator: Yong Park, MD
A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive
Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment
in Pediatric Subjects 1 to less than 4 years of age with Inadequately Controlled Lennox-Gastaut
Syndrome
Principal Investigator: Yong Park, MD
Recently Completed Studies:
Safety and Effectiveness of Open-Label Clobazam in Subjects with Lennox-Gastaut Syndrome
Principal Invertigator: Yong Park, MD
An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-on Antiepileptic
Drug (AED) Treatment in Subjects with Partial-Onset Seizures
Principal Investigator: Yong Park, MD
For more information, please call me at 706-721-6260.
Thank you,
|
Patty Ray, Ph.D.
Director, Clinical Epilepsy Trials Program
Associate Professor
Department of Neurology
paray@gru.edu
|
 |
